Chao Guan-Qun, Zhang Shuo
Guan-Qun Chao, Department of Family Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou 310006, Zhejiang Province, China.
World J Gastroenterol. 2014 Feb 21;20(7):1871-7. doi: 10.3748/wjg.v20.i7.1871.
To evaluate the efficacy of acupuncture for treatment of irritable bowel syndrome (IBS) through meta-analysis of randomized controlled trials.
We searched MEDLIINE, PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials from 1966 to February 2013 for double-blind, placebo-controlled trials investigating the efficacy of acupuncture in the management of IBS. Studies were screened for inclusion based on randomization, controls, and measurable outcomes reported. We used the modified Jadad score for assessing the quality of the articles. STATA 11.0 and Revman 5.0 were used for meta-analysis. Publication bias was assessed by Begg's and Egger's tests.
Six randomized, placebo-controlled clinical trials met the criteria and were included in the meta-analysis. The modified Jadad score of the articles was > 3, and five articles were of high quality. We analyzed the heterogeneity and found that these studies did not cause heterogeneity in our meta-analysis. Begg's test showed P = 0.707 and Egger's test showed P = 0.334. There was no publication bias in our meta-analysis (Begg's test, P = 0.707; Egger's test, P = 0.334). From the forest plot, the diamond was on the right side of the vertical line and did not intersect with the line. The pooled relative risk for clinical improvement with acupuncture was 1.75 (95%CI: 1.24-2.46, P = 0.001). Using the two different systems of STATA 11.0 and Revman 5.0, we confirmed the significant efficacy of acupuncture for treating IBS.
Acupuncture exhibits clinically and statistically significant control of IBS symptoms.
通过对随机对照试验的荟萃分析,评估针刺治疗肠易激综合征(IBS)的疗效。
我们检索了1966年至2013年2月期间的MEDLIINE、PubMed、Scopus、Web of Science和Cochrane对照试验中央注册库,以查找调查针刺治疗IBS疗效的双盲、安慰剂对照试验。根据随机化、对照和报告的可测量结果筛选纳入研究。我们使用改良的Jadad评分评估文章质量。使用STATA 11.0和Revman 5.0进行荟萃分析。通过Begg检验和Egger检验评估发表偏倚。
六项随机、安慰剂对照临床试验符合标准并纳入荟萃分析。文章的改良Jadad评分>3,五篇文章质量高。我们分析了异质性,发现这些研究在我们的荟萃分析中未引起异质性。Begg检验显示P = 0.707,Egger检验显示P = 0.334。我们的荟萃分析中没有发表偏倚(Begg检验,P = 0.707;Egger检验,P = 0.334)。从森林图来看,菱形位于垂直线右侧且未与该线相交。针刺治疗临床改善的合并相对风险为1.75(95%CI:1.24 - 2.46,P = 0.001)。使用STATA 11.0和Revman 5.0这两种不同系统,我们证实了针刺治疗IBS的显著疗效。
针刺在临床上和统计学上对IBS症状具有显著的控制作用。